Daiichi Sankyo Co., Ltd. v. MATRIX LABORATORIES

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• explaining that more than mere structural similarity must be identified as a reason to select a compound as a lead compound; “knowledge in the art of the functional properties and limitations of the prior art compounds” are also important to the analysis
• “Potent and promising activity in the prior art trumps mere structural relationships.”

Source: CourtListener parenthetical corpus (CC0).

Cited by

14 cases in this archive cite this case.

• OTSUKA PHARMACEUTICAL CO., LTD. v. Sandoz, Inc.
  Federal Circuit· 2012-05-07· cited 59×
• Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA, Inc.
  Federal Circuit· 2014-06-12· cited 52×
• Cheese Systems, Inc. v. Tetra Pak Cheese & Powder Systems, Inc.
  Federal Circuit· 2013-08-06· cited 25×
• Yeda Research and Development v. Mylan Pharmaceuticals Inc.
  Federal Circuit· 2018-10-12· cited 25×
• Anacor Pharmaceuticals, Inc. v. Iancu
  Federal Circuit· 2018-05-14· cited 22×
• Novartis Pharmaceuticals Corp v. West-Ward Pharmaceuticals
  Federal Circuit· 2019-05-13· cited 17×
• Bristol-Myers Squibb Co. v. Teva Pharmaceuticals USA, Inc.
  D. Delaware· 2013-02-11· cited 13×
• Valeant Pharmaceuticals Intl. v. Mylan Pharmaceuticals Inc.
  Federal Circuit· 2020-04-08· cited 12×
• Apotex, Inc. v. Daiichi Sankyo, Inc.
  Federal Circuit· 2015-03-31· cited 10×
• BTG Int'l Ltd. v. Amneal Pharm. LLC
  D. New Jersey· 2018-10-31· cited 9×
• AstraZeneca AB v. Aurobindo Pharma Ltd.
  D. Delaware· 2017-02-02· cited 8×
• Pfizer Inc. v. Mylan Pharmaceuticals Inc.
  D. Delaware· 2014-10-22· cited 3×
• OSI Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
  D. Delaware· 2012-05-01· cited 2×
• Mylan Inc. v. Daiichi Sankyo Co.
  Supreme Court· 2011-03-21

Cites

11 cases in this archive are cited by this case.

• United States v. United States Gypsum Co.
  Supreme Court· 1948-03-08· cited 9,383×
• Graham v. John Deere Co. of Kansas City
  Supreme Court· 1966-02-21· cited 3,371×
• KSR International Co. v. Teleflex Inc.
  Supreme Court· 2007-04-30· cited 1,310×
• Ortho-McNeil Pharmaceutical, Inc. v. Mylan Laboratories, Inc.
  Federal Circuit· 2008-03-31· cited 141×
• Takeda Chemical Industries, Ltd. v. Alphapharm Pty., Ltd.
  Federal Circuit· 2007-06-28· cited 114×
• Golden Blount, Inc. v. Robert H. Peterson Co.
  Federal Circuit· 2004-04-19· cited 103×
• Eli Lilly & Co. v. Zenith Goldline Pharmaceuticals, Inc.
  Federal Circuit· 2006-12-26· cited 97×
• Altana Pharma AG v. Teva Pharmaceuticals USA, Inc.
  Federal Circuit· 2009-05-14· cited 83×
• In Re Diane M. Dillon
  Federal Circuit· 1990-11-09· cited 74×
• Eisai Co. Ltd. v. Dr. Reddy's Laboratories, Ltd.
  Federal Circuit· 2008-07-21· cited 72×
• Daiichi Sankyo Co. v. Mylan Pharmaceuticals Inc.
  D. New Jersey· 2009-07-30· cited 3×